Private Equity

  • May 20, 2026

    Eli Lilly Paying Up To $202M In Genetic Medicine Deal

    Eli Lilly and Co. has agreed to acquire privately held Engage Biologics Inc., which is developing a delivery technology for genetic medicines, in a deal worth up to $202 million, Cooley LLP-advised Engage announced Wednesday.

  • May 20, 2026

    StraightPath Trio Gets Prison For Defrauding Pre-IPO Clients

    A Manhattan federal judge sentenced stock vendor StraightPath's three founders to around a decade each in prison Wednesday, after a jury convicted them of defrauding clients who bought $400 million of pre-initial public offering shares from their Florida private equity firm.

  • May 20, 2026

    Kirkland-Led Shamrock Wraps $813M Media Acquisition Fund

    Kirkland & Ellis LLP-advised media and entertainment-focused investment firm Shamrock Capital on Wednesday revealed that it had closed its fourth content acquisition fund with $813 million in total capital commitments.

  • May 19, 2026

    Shoppers Seek Fees At 9th Circ. For Kroger, Albertsons Fight

    Counsel for grocery store consumers urged the Ninth Circuit on Tuesday to find they substantially prevailed in their proposed class action challenging Kroger's since-abandoned $24.6 billion bid for Albertsons and are entitled to attorney fees, arguing that the lower court wrongly concluded the case was mooted by other federal actions blocking the merger.

  • May 19, 2026

    Premiums To Struggling Insurer Are 'Debts,' Conn. Panel Told

    PHL Variable Insurance Co. life insurance policyholders on Tuesday accused Connecticut's interim insurance commissioner of bankrolling the struggling insurer's rehabilitation by receiving millions without guaranteeing at least some payout, urging a state appeals court to reverse a trial judge's conclusion that premiums are not "debts."

  • May 19, 2026

    McDermott-Led Albaron Wraps $185M Healthcare Fund

    Albaron Partners, advised by McDermott Will & Schulte, on Tuesday revealed it has closed its flagship fund after securing $185 million in commitments, which will be used to invest in healthcare companies.

  • May 19, 2026

    Mentari, InMed Merge In Deal Backed By $290M Funding

    InMed Pharmaceuticals Inc. on Tuesday announced plans to merge with migraine prevention drugmaker Mentari Therapeutics Inc. in an all-stock deal that is backed by a $290 million private placement and was guided by three law firms.

  • May 19, 2026

    FTC Wants 5th Circ. To Pause Appeal In Merger Filing Case

    The Federal Trade Commission asked the Fifth Circuit to put its appeal on hold in a case challenging the agency's effort to overhaul its premerger filing requirements, to give enforcers time to consider developing a new revision.

  • May 19, 2026

    NC Judge OKs DOJ, RealPage Deal In Antitrust Suit

    A North Carolina federal judge signed off on the U.S. Department of Justice's settlement with RealPage, the latest development in a suit alleging landlords coordinated to inflate rental prices via the company's algorithmic pricing software.

  • May 19, 2026

    Stellus Wraps 4th Credit Fund With $1.5B In Tow

    Lower middle market direct lender Stellus Capital Management LLC on Tuesday revealed that it closed its fourth credit fund with $1.5 billion in tow.

  • May 19, 2026

    THL Partners' Agiliti Buyout Suit To Settle For $32M

    A proposed $32 million settlement would end consolidated Delaware Chancery Court litigation challenging private equity firm Thomas H. Lee Partners LP's $2.5 billion take-private acquisition of medical equipment company Agiliti Inc., resolving claims that minority stockholders were squeezed out at an unfair price.

  • May 19, 2026

    Maynard Nexsen Adds Transactional Tax Pro In NC

    Maynard Nexsen PC announced that it has added a partner to the firm's tax practice group from Nelson Mullins Riley & Scarborough LLP, adding that the Charlotte, North Carolina, hire brings expertise in transactional tax structuring and planning.

  • May 18, 2026

    Nikola Founder Accused Of Dodging $2.5M Settlement Share

    Nikola Corp. founder Trevor Milton "has not paid a dime" of his $2.5 million share of an eight-figure settlement resolving shareholder litigation over a fraud-shadowed special purpose acquisition company merger, the bankrupt electric vehicle company's trustee claims, asking the Delaware Chancery Court to hold the billionaire in contempt.

  • May 18, 2026

    Health Co. Wants Kirkland Off IP Case For 'Cardinal Sin'

    A healthcare company suing medical technology company Commure Inc. over alleged trade secret theft has said Kirkland & Ellis LLP should be disqualified from representing Commure because the healthcare company had tried to retain Kirkland prior to filing the suit and shared confidential information before anyone asked who the defendant was going to be.

  • May 18, 2026

    Ropes Steers Bain Capital's Above-Target $10.5B Asia Fund

    Ropes & Gray LLP-advised private equity giant Bain Capital has wrapped fundraising on its sixth Asia-focused fund after securing $10.5 billion in total capital.

  • May 18, 2026

    SEC Ends 'Gag Rule' Policy For Enforcement Settlements

    The U.S. Securities and Exchange Commission on Monday scrapped a decades-old enforcement policy that prohibited settling parties from denying the agency's allegations against them, saying the policy made it appear as though the SEC was trying to "shield itself from criticism."

  • May 18, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week handled a broad mix of celebrity estate litigation, merger disputes, investor suits, record demands, sanctions fights and questions over corporate moves away from Delaware.

  • May 18, 2026

    OpenAI Beats Musk Suit Over For-Profit Restructuring

    In an advisory decision Monday, a California federal jury cleared OpenAI and executives Sam Altman and Greg Brockman of allegations they breached the nonprofit's charitable trust by converting to a for-profit, handing billionaire Elon Musk a defeat in a closely watched three-week trial that threatened to shake up the artificial intelligence industry.

  • May 15, 2026

    Citron Founder Phoned Fed. Agent During FBI Raid, Jury Told

    An inspector with the U.S. Postal Service told a California federal jury considering securities fraud charges against Citron Research founder Andrew Left on Friday that even as she participated in the FBI's raid of his home, Left called her and spoke at length about the allegations against him for over an hour. 

  • May 15, 2026

    Cerebras' Mega IPO Boosts Confidence In AI Pipeline

    Artificial intelligence computing company Cerebras Systems Inc.'s blockbuster debut was well received by deals attorneys who track the pipeline for initial public offerings, with lawyers saying the upsized $5.6 billion IPO is a sign that investor confidence in the AI sector is growing. 

  • May 15, 2026

    Metal Card Maker Sued Over $5B Deal, Nevada Move From Del.

    A stockholder of the company behind premium metal credit cards has sued in Delaware Chancery Court claiming that a group of investor-directors turned the once-focused card manufacturer into a vehicle for extracting management fees and then tried to move the company to Nevada as litigation pressure mounted.

  • May 15, 2026

    How US Policy, Capital Flows Are Reshaping Defense M&A

    Defense dealmaking is showing signs of broadening in 2026, with government-backed investment and expanded participation from smaller technology-focused players accelerating transactions even as headline deal values moderate from last year's highs.

  • May 15, 2026

    4 Key Takeaways From SEC's Semiannual Reporting Proposal

    The U.S. Securities and Exchange Commission recently put forth a plan that could allow publicly traded companies to move from a quarterly to a semiannual reporting schedule, but whether they choose to do so and how that could impact both the growth of the public markets and insider-trading plans for corporate leaders remains up for debate.

  • May 15, 2026

    Proskauer Welcomes 2 New Partners To NY Office

    Proskauer Rose LLP announced this week that it has added two partners to its New York office — a restructuring attorney who joins from Davis Polk & Wardwell LLP and a private funds attorney who comes from advisory-focused investment bank PJT Partners.

  • May 15, 2026

    Turkish Fintech Exec Cops To Duping Venture Capital Backers

    A fintech executive from Turkey copped to a count of securities fraud Friday, telling a Manhattan federal judge that she lied to seed-round investors who backed her Kalder Inc. startup and agreeing to forfeit about $7 million.

Expert Analysis

  • SEC Rulemaking Radar: The Debut Of Atkins' 'New Day'

    Author Photo

    The U.S. Securities and Exchange Commission's regulatory flex agenda, published last week, demonstrates a clear return to appropriately tailored and mission-focused rulemaking, with potential new rules applicable to brokers, exchanges and trading, among others, say attorneys at Goodwin.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • What To Expect As Trump's 401(k) Order Materializes

    Author Photo

    Following the Trump administration’s recent executive order on 401(k) plan investments in alternative assets like cryptocurrencies and real estate, the U.S. Department of Labor and the U.S. Securities and Exchange Commission will need to answer several outstanding questions before any regulatory changes are implemented, say attorneys at Cleary.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • With Obligor Ruling, Ohio Justices Calm Lending Waters

    Author Photo

    A recent decision by the Ohio Supreme Court, affirming a fundamental principle that lenders have no duty to disclose material risks to obligors, provides clarity for commercial lending practices in Ohio and beyond, and offers a reminder of the risks presented by guarantee arrangements, says Carrie Brosius at Vorys.

  • Evaluating The SEC's Rising Whistleblower Denial Rate

    Author Photo

    The rising trend of U.S. Securities and Exchange Commission whistleblower award claim denials represents a departure from the SEC's previous track record and may reflect a more conservative approach to whistleblower award determinations under the current administration, say attorneys at Troutman Pepper.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Unpacking The New Opportunity Zone Tax Incentive Program

    Author Photo

    The One Big Beautiful Bill Act brought several improvements to the opportunity zone tax incentive program that should boost investments in qualified funds, including making it permanent, increasing federal income tax benefits in rural areas, redesignating the qualified zones, and requiring more in-depth reporting, says Marc Schultz at Snell & Wilmer.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • Navigating Brazil's Regulations, Incentives For Green Projects

    Author Photo

    Brazil's evolving environmental regulatory framework and ongoing moves to attract international capital for climate-focused projects may appeal to U.S.-based companies and investors interested in sustainable development — but taking advantage of these opportunities requires careful planning and meaningful stakeholder engagement, says Milena Angulo at Guimarães.

  • Texas Property Law Complicates Financing And Development

    Author Photo

    A new Texas law imposing expansive state-level restrictions on properties owned by entities from designated countries creates a major obstacle for some lenders, developers and other stakeholders, as well as new diligence requirements for foreign companies, say attorneys at Pillsbury.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.